Connecting Patients to Clinical Trials

Developing innovative technologies and media for facilitating patient recruitment

TrialX enables...


such as Cinda to find trials for herself and her loved ones

Search Trials


such as Jennifer to complete her clinical trial recruitment on time

Upload Your Trial


such as the Cleveland Clinic to create a centralized trial listing and recruitment tool

Learn More


such as the MMRF to create awareness for research and trials

Learn More

Why customers love TrialX.

Innovative Technology

Developed using an award winning semantic technology that matches patients to trials using their full-clinical record and clinical trial inclusion/exclusion criteria. Recently, we developed another novel interactive question/answering technology (winner of the 2011 NCI/Health 2.0 Developer Challenge) that guides and connects patients to research site using live calls

Great User Experience

At TrialX, we develop tools that we'd like to use. We continually refine the user interface and the flow to make it even easier for our customers to do their tasks effectively.

Customer Service

We Listen. We listen to what our customers say and often we fix/add features even before they tell us. The secret sauce of our awesome customer service is that we also "listen" to DATA. We mine access logs, error logs to solve problems before they arise (sort of like the Minory Report!)

I have been very pleased with the recruitment effort of TrialX for my research studies. They have been very diligent in finding qualified subjects in a reasonable time frame. I would definitely recommend their services to clinical research sites.

Dr. Arthur Waldbaum MD
  • What was I doing three years ago?  Recovering from an autologous (using my own cells) stem cell transplant at Moffitt Cancer Center.  Has it really been three years? My sister, Joan, and our good friends from Wisconsin, Tim and Lisa Hanna,  each flew down to Florida for ten days to help. Tim was–and still is–the […]
  • I started radiation therapy today.  It took longer than session’s I’ve experienced in the past; something to do with getting the monster machine rotated from one hip to the other. To review, it has become painful for me to push off when I walk, get up from a chair or in and out of bed.  […]
  • Dr. Bart Barlogie is a myeloma legend.  Love him or hate him, his unbridled obsession for finding a multiple myeloma cure has been relentless. The father of Total Therapy, Dr. Barlogie has helped the University of Arkansas Medical School (UAMS) develop one of the world’s foremost multiple myeloma treatment centers, known as the Myeloma Institute […]
  • Wednesday our Cure Talk panel was fortunate to spend over an hour with Emory University’s Dr. Sagar Lonial, a well known myeloma specialist.  The focus was on ways to treat high risk multiple myeloma patients most effectively. I was pleased by how well the hour went.  No real technical glitches.  Intelligent questions from our panel […]
  • If you missed Emory's Dr. Sagar Lonial's broadcast on High Risk Myeloma,  you missed an excellent and informative program.  You can still hear a rebroadcast of the program if you CLICK HERE!  I do think the major takeaway from Dr. Lonial's presentation was the excellent res [...]
  • I may have written before about how much I love my new, four row pillbox.  Room for the dozen of pills and capsules that I take morning, noon and before my evening meal. The fourth row is for bedtime; handy compartments to house things like Tuesday night’s 10, 4 mg little green dexamethasone pills.  And […]
  • Floridian Jenny Hack is a regular reader and member of the Jacksonville Multiple Myeloma support group.  I met her a number of years ago, and was happy to see her again at the meeting last week.  Jenny has become a focused and dedicated activist, working hard to help get oral chemotherapy meds paid for like […]
  • It is so sad to hear that Arnie has passed away.  We met him briefly at your beach party, and I am sorry now that I didn’t take the time to visit longer.  I think back when I was first diagnosed, and I became somewhat familiar with the regulars who posted here almost five years […]
  • The promise of becoming part of exciting, new clinical trials can be intoxicating.  But most only work for less than half of the patients that sign up. Here’s an update from a Patient Snapshot alumnus, Chuck.  Sounds like he’s one of the unlucky ones: Pat, Rewinding to my last update: I was just starting […]
  • I’m feeling much better.  Time to focus on something other than me! Doris Peterkin emailed me last week, looking for participants in a promising clinical trial that her company is expanding: Dear Pat, I am writing to you because I am a fan of your website and have admired your openness about your struggles with […]
  • Thanks for all of your thoughtful comments and emails! I’m still running a low grade temp, but I’m eating again and feeling stronger today–and my congestion is improving, too.  So news on that front is all good.  While I was at it, I thought I would add an update about what else myeloma related going […]
  • Never a dull moment.  I woke up last night with a 101 degree fever.  It’s my fault; I pushed too hard this week. I’m not ashamed to admit that getting sick like this is unsettling.  I’m congested and an upset stomach makes it difficult to eat.  I spent the day sleeping and trying to stay […]
  • A few days ago I wrote a skeptical post about a supplement called IP6.  I have received a number of comments and emails supporting the use of IP6 since then.  I’m good with that.  It may or may not help slow the advance of multiple myeloma. Susierose kindly forwarded me this research article about IP6 […]
  • I was fortunate to be a guest at the multiple myeloma support group that meets monthly at Mayo Clinic in Jacksonville last evening.  But it wasn’t my first visit.  Five years ago I drove across Florida to speak to the group and promote my first book, Living with Multiple Myeloma. I remember the trip well.  […]
  • *** Can Success with High Risk Myeloma mean the cure for all myeloma is getting closer? Dr. Sagar Lonial of Emory University discussed High Risk Disease and his teams success at the treatment of this extremely hard to treat form of myeloma on the August Cure Panel Broadcast .  You can listen to the rebroadcast of this exceptional program if you  [...]
  • Anyone familiar with a supplement called IP6?  A reader, Richard, swears it has stopped his myeloma in its tracks when other more conventional meds weren’t helping at all. Myeloma Cinderella’s suzierose must be in contact with Richard, too.  I see she wrote a post about it back in January: Dr. Shamsuddin Cancer Researcher and IP6 […]
  • Palliative care is specialized medical care for people with serious illnesses. It focuses on providing patients with relief from the symptoms, pain, and stress of a serious illness—whatever the diagnosis. The goal is to improve quality of life for both the patient and the family. Often mistakenly identified as end-of-life or hospice therapy, palliative care is […]
  • Disappointing news.  After dropping my M-spike from 0.7 to 0.4 the first month, my spike jumped back up to 0.6 this month.  Two months on pomalidomide and I’m right back where I started. I know, I know.  Lab numbers often jump around and vary from month to month.  As a rule, mine haven’t, but that […]
  • On the surface this doesn’t seem like big news.  But grind-it-out studies like these are important.  They help medical oncologists that aren’t going to experiment off-label know what to do after a patient relapses. Here’s Millennium Pharmaceutical’s press release about it: FDA Approves VELCADE® (bortezomib) Retreatment in Patients with Multiple Myeloma  August 8, 2014 CAMBRIDGE, […]
  • Remission.  Complete response (CR).  Stringent complete response (sCR).  Minimal residual disease (MRD).  All technical terms that seemingly have precise and specific meanings. But this enlightening newspaper column, written by a former copy editor and multiple myeloma survivor in Maine, makes a point that I’ve been stressing for years: a lot of myeloma patients and caregivers […]